Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
SOLUTION
OPHTHALMIC
Medical Information
S01GX03
spaglumic acid
Manufacturer Information
DCH AURIGA SINGAPORE
LABORATOIRES THISSEN SA
EXCELVISION
Active Ingredients
N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT
4.9%
n-acetyl aspartyl glutamic acid sodium salt